H.‐J. Lüddeke

Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study*

L. F. Meneghini, Kirsten Rosenberg, Christoph Koenen et al. · Diabetes Obesity and Metabolism · 2006 · 100 citations · Full text

PREDICTIVE™– a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort

H.‐J. Lüddeke, Séamus Sreenan, Stefan Aczél et al. · Diabetes Obesity and Metabolism · 2006 · 86 citations

Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal‐only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14‐week follow‐up data from PREDICTIVE™

Anne Dornhorst, H.‐J. Lüddeke, Christoph Koenen et al. · Diabetes Obesity and Metabolism · 2007 · 56 citations